VALERE KOSKI: Open Payments
NPI 1912611401 · LIBERTY HILL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 30 payments from 9 companies in 2025. Trend: 2023 $1,035 · 2024 $1,512 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 7 | $113 |
| Novo Nordisk Inc | 6 | $104 |
| PFIZER INC. | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Stryker Corporation | 1 | $44 |
| Amgen Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: Kerendia, AIRSUPRA, Wegovy, TRELEGY ELLIPTA, ALPHAVENT, OTEZLA, FARXIGA, ELIQUIS.
Industry payments across TX — which companies pay providers there.
